Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Oxford strengthens international collaboration to solve epidemic global health problem

Research

An innovative Oxford research project will explore the relationship between metabolism and inflammation in metabolic diseases. Obesity, insulin resistance, type 2 diabetes (T2D) and associated cardiovascular disease (CVD) – all metabolic diseases – are an epidemic global health problem.

Oxford strengthens international collaboration to solve epidemic global health problem © kwanchai.c - Shutterstock

Image courtesy of Shutterstock

Obesity, insulin resistance, type 2 diabetes (T2D) and associated cardiovascular disease (CVD) – all metabolic diseases – are an epidemic global health problem.

With almost 400 million people worldwide suffering from T2D and total deaths from the condition due to rise by more than 50% in the next 10 years, research which addresses the causes of these diseases and delivers effective treatment for them is of paramount importance. So two Oxford teams are beginning research programmes, funded by the Novo Nordisk Foundation.

Read more